| Market Cap | ₹4,30,513Cr |
| ROE | 14.84% |
| P/E Ratio(TTM) | 41.06 |
| EPS(TTM) | 43.70 |
| P/B Ratio | 5.53 |
| Dividend Yield | 0.89% |
| Industry P/E | 33.29 |
| Book Value | 324.34 |
| Debt to Equity | 0.07 |
| Face Value | 1 |
| Parent Organisation | Sun Pharmaceutical Industries Limited |
| Managing Director | Dilip S. Shanghvi |
| NSE Symbol | SUNPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cipla | NA (0.00%) | 22.55 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.62 | ||
| Lupin | NA (0.00%) | 22.21 | ||
| Zydus Lifesciences | NA (0.00%) | 18.59 |